Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Shakado

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Current Oncology (Toronto, Ont.)|July 25, 2022
Pretreatment Modified Albumin-Bilirubin Grade Is an Important Predictive Factor Associated with the Therapeutic Response and the Continuation of Atezolizumab plus Bevacizumab Combination Therapy for Patients with Unresectable Hepatocellular CarcinomaTakashi Tanaka, Kazuhide Takata, Keiji Yokoyama, et al.
Clinical Journal of Gastroenterology|December 10, 2022
Complete tumor necrosis confirmed by conversion hepatectomy after atezolizumab-bevacizumab treatment for advanced-stage hepatocellular carcinoma with lung metastasisAtsushi Fukunaga, Kazuhide Takata, Shinji Itoh, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 5, 2017
Efficacy of sofosbuvir and ledipasvir therapy in patients co-infected with hepatitis C virus genotypes 1 and 2Tetsuro Sohda, Keiji Yokoyama, Eri Yamauchi, et al.
Medical Molecular Morphology|April 4, 2013
3-Hydroxyl-3-methylglutaryl-coenzyme A reductase is up regulated in hepatocellular carcinoma associated with paraneoplastic hypercholesterolemiaTetsuro Sohda, Kaoru Iwata, Genryu Hirano, et al.
Clinical Journal of Gastroenterology|March 21, 2024
Two cases of severe oral mucositis caused by atezolizumab plus bevacizumab combination therapy for hepatocellular carcinomaYasuharu Shimoji, Ryo Yamauchi, Kumiko Shibata, et al.
Clinical Journal of Gastroenterology|October 25, 2023
Partial splenic embolization improved stomal varices in patient with decompensated liver cirrhosis: a case reportRyo Yamauchi, Kazuhide Takata, Keiji Yokoyama, et al.
Hepatology International|August 12, 2009
Spontaneous rupture of metastatic alpha-fetoprotein-producing gastric cancer of the liverTetsuro Sohda, Takayuki Hanano, Hisanori Miyamoto, et al.
Ultrasound in Medicine & Biology|April 10, 2022
Clinical Utility of Ultrasound-Guided Attenuation Parameter for the Detection and Quantification of Hepatic Steatosis in Patients with Fatty Liver Diagnosed by Computed TomographyHideyuki Iwashita, Satoshi Shakado, Namiko Yoshimaru, et al.
Scandinavian Journal of Gastroenterology|May 14, 2019
Safety and efficacy of cold polypectomy compared to endoscopic mucosal resection and hot biopsy polypectomyHideyuki Iwashita, Hidetoshi Takedatsu, Hiroyuki Murao, et al.
Scientific Reports|September 28, 2023
Long-term outcome and eligibility of radiofrequency ablation for hepatocellular carcinoma over 3.0 cm in diameterTakashi Tanaka, Kazuhide Takata, Takashi Miyayama, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Current Oncology (Toronto, Ont.)|July 25, 2022
Pretreatment Modified Albumin-Bilirubin Grade Is an Important Predictive Factor Associated with the Therapeutic Response and the Continuation of Atezolizumab plus Bevacizumab Combination Therapy for Patients with Unresectable Hepatocellular CarcinomaTakashi Tanaka, Kazuhide Takata, Keiji Yokoyama, et al.
Clinical Journal of Gastroenterology|December 10, 2022
Complete tumor necrosis confirmed by conversion hepatectomy after atezolizumab-bevacizumab treatment for advanced-stage hepatocellular carcinoma with lung metastasisAtsushi Fukunaga, Kazuhide Takata, Shinji Itoh, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 5, 2017
Efficacy of sofosbuvir and ledipasvir therapy in patients co-infected with hepatitis C virus genotypes 1 and 2Tetsuro Sohda, Keiji Yokoyama, Eri Yamauchi, et al.
Medical Molecular Morphology|April 4, 2013
3-Hydroxyl-3-methylglutaryl-coenzyme A reductase is up regulated in hepatocellular carcinoma associated with paraneoplastic hypercholesterolemiaTetsuro Sohda, Kaoru Iwata, Genryu Hirano, et al.
Clinical Journal of Gastroenterology|March 21, 2024
Two cases of severe oral mucositis caused by atezolizumab plus bevacizumab combination therapy for hepatocellular carcinomaYasuharu Shimoji, Ryo Yamauchi, Kumiko Shibata, et al.
Clinical Journal of Gastroenterology|October 25, 2023
Partial splenic embolization improved stomal varices in patient with decompensated liver cirrhosis: a case reportRyo Yamauchi, Kazuhide Takata, Keiji Yokoyama, et al.
Hepatology International|August 12, 2009
Spontaneous rupture of metastatic alpha-fetoprotein-producing gastric cancer of the liverTetsuro Sohda, Takayuki Hanano, Hisanori Miyamoto, et al.
Ultrasound in Medicine & Biology|April 10, 2022
Clinical Utility of Ultrasound-Guided Attenuation Parameter for the Detection and Quantification of Hepatic Steatosis in Patients with Fatty Liver Diagnosed by Computed TomographyHideyuki Iwashita, Satoshi Shakado, Namiko Yoshimaru, et al.
Scandinavian Journal of Gastroenterology|May 14, 2019
Safety and efficacy of cold polypectomy compared to endoscopic mucosal resection and hot biopsy polypectomyHideyuki Iwashita, Hidetoshi Takedatsu, Hiroyuki Murao, et al.
Scientific Reports|September 28, 2023
Long-term outcome and eligibility of radiofrequency ablation for hepatocellular carcinoma over 3.0 cm in diameterTakashi Tanaka, Kazuhide Takata, Takashi Miyayama, et al.
Pageof 9